# Gujarat Kidney and Super Speciality Ltd (GKSL)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹143.27
Day Change: +2.72%
52W High: ₹147.9
52W Low: ₹98.25
Market Cap: ₹1,082 Cr

## Valuation
P/E: 63.25
P/B: 30.08
EPS: ₹2.17
Book Value: ₹4.56
Dividend Yield: 0%

## Returns
1Y Return: 0%

## Profitability
ROE: 0%
ROCE: 39.38%
Debt/Equity: 0
Revenue Growth: 97.2%
Profit Growth: 0%
EBITDA Margin: 36.02%
Operating Margin: 23.94%

## About
Gujarat Kidney and Super Speciality Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: Gujarat Kidney and Super Speciality Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
- Announcement: Announcement under Regulation 30 (LODR)-Monitoring Agency Report
- BSE Filing: Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

## Access
Current tier: anonymous
More history: Register free to see 1 more year.

## Data Freshness
Quote Updated: 2026-05-24T20:00:07.443Z
Price History Updated: 2026-05-18T22:59:06.855Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:59:06.855Z
Quant Updated: 2026-05-18T22:59:06.855Z
Sentiment Updated: 2026-05-18T22:59:06.855Z
Financials Status: current
Financials Updated: 2026-05-19T02:31:25.073Z
Financials Last Attempt: 2026-05-19T02:31:25.073Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (FY25)
Revenue: ₹119.97 Cr
Operating Profit: ₹22.38 Cr (OPM 18.65%)
Net Profit: ₹14.74 Cr
Tax: ₹5.36 Cr

## Annual P&L History
FY25: Rev ₹119.97Cr | PAT ₹14.74Cr | OPM 18.65%
FY24: Rev ₹103.44Cr | PAT ₹9.68Cr | OPM 14.25%
FY23: Rev ₹85.79Cr | PAT ₹6.64Cr | OPM 13.52%

## Balance Sheet (FY25)
Total Assets: ₹91.29 Cr
Total Liabilities: ₹51.46 Cr
Borrowings: ₹22.77 Cr
Cash: ₹4.58 Cr

## Shareholding
undefined: undefined%

## Board
- Pragnesh Yashwantsinh Bharpoda, Chairman & MD
- Bhavikaben Mitesh Patel, Chief Financial Officer
- Vishakha Mahesh Phadke, Company Secretary & Compliance Officer
- Kunal Harishbhai Shah, Senior Anaesthetist & Head of Department
- Hardikbhai Jamandas Gajera, Senior Nephrologist & Head of Department

---
Source: rupiya.io/stocks/gksl
Disclaimer: For research and education only. Not investment advice.